| GPC5, a tumor suppressor, is regulated by miR-620 in lung adenocarcinoma. | lung, |
| Glypican-5 is a tumor suppressor in non-small cell lung cancer cells | lung, |
| GPC5 is a novel epigenetically silenced tumor suppressor, which inhibits tumor growth by suppressing Wnt/beta-catenin signaling in lung adenocarcinoma. | lung, |
| Taken together, our results suggest GPC5 as a tumor suppressor in PDAC and its expression is possibly regulated by miR-4295. Our study indicates that the miR-4295/GPC5 axis may play an important role in the pathogenesis of PADC and has potential applications for the development of PDAC therapy. | None |